Egetis Therapeutics AB (publ) (EGTX) — Net Asset Quality Index
Egetis Therapeutics AB (publ) (EGTX) has a Net Asset Quality Index of 54.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr654.40 Million minus total liabilities of Skr299.30 Million yields net assets of Skr355.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore EGTX total assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Egetis Therapeutics AB (publ) Net Asset Quality Index Over Time (2008–2024)
This chart shows how Egetis Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at 54.3%, representing net assets of Skr355.10 Million against total assets of Skr654.40 Million SEK. See EGTX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Egetis Therapeutics AB (publ) (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Egetis Therapeutics AB (publ) from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Egetis Therapeutics AB (publ).
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 62.2% | Skr492.90 Million | Skr792.30 Million | Skr299.40 Million | ▼ -9.6 pp |
| 2023 | 71.8% | Skr545.60 Million | Skr760.20 Million | Skr214.60 Million | ▼ -18.4 pp |
| 2022 | 90.2% | Skr506.20 Million | Skr561.10 Million | Skr54.90 Million | ▼ -2.4 pp |
| 2021 | 92.6% | Skr527.04 Million | Skr569.27 Million | Skr42.23 Million | ▲ +22.2 pp |
| 2020 | 70.4% | Skr629.63 Million | Skr893.97 Million | Skr264.34 Million | ▼ -20.2 pp |
| 2019 | 90.7% | Skr244.88 Million | Skr270.07 Million | Skr25.20 Million | ▲ +0.0 pp |
| 2018 | 90.6% | Skr219.36 Million | Skr242.04 Million | Skr22.68 Million | ▼ -5.7 pp |
| 2017 | 96.3% | Skr303.71 Million | Skr315.37 Million | Skr11.66 Million | ▼ -2.0 pp |
| 2016 | 98.3% | Skr389.56 Million | Skr396.44 Million | Skr6.87 Million | ▲ +6.5 pp |
| 2015 | 91.7% | Skr48.03 Million | Skr52.36 Million | Skr4.33 Million | ▲ +4.1 pp |
| 2014 | 87.6% | Skr90.66 Million | Skr103.47 Million | Skr12.81 Million | ▼ -4.4 pp |
| 2013 | 92.0% | Skr46.95 Million | Skr51.01 Million | Skr4.06 Million | ▲ +2.8 pp |
| 2012 | 89.2% | Skr53.94 Million | Skr60.46 Million | Skr6.52 Million | ▼ -6.5 pp |
| 2011 | 95.7% | Skr87.53 Million | Skr91.42 Million | Skr3.89 Million | ▲ +13.4 pp |
| 2010 | 82.3% | Skr6.99 Million | Skr8.49 Million | Skr1.50 Million | ▼ -13.1 pp |
| 2009 | 95.4% | Skr5.64 Million | Skr5.91 Million | Skr273.98K | ▲ +1.4 pp |
| 2008 | 94.0% | Skr5.05 Million | Skr5.37 Million | Skr323.55K | — |